Why Is Fintepla So Hard to Find? [Explained for 2026]

If you or your child has been prescribed Fintepla (fenfluramine) for Dravet syndrome or Lennox-Gastaut syndrome (LGS), you may have quickly discovered that filling this prescription isn't as simple as walking into any pharmacy. Many families spend hours calling pharmacies, only to be told: "We don't carry that."

But here's the thing: Fintepla isn't hard to find because of a shortage. It's restricted by design. Understanding why — and knowing what to do about it — can save you enormous stress.

What Is Fintepla, and Who Is It For?

Fintepla (generic name: fenfluramine) is an oral solution approved by the FDA for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older. It was first approved for Dravet syndrome in June 2020, and received its second approval for LGS in March 2022.

Both Dravet syndrome and LGS are rare and severe forms of epilepsy that are notoriously difficult to treat. Fintepla is considered a second-line add-on therapy for Dravet syndrome patients who continue to have seizures despite first-line treatment with valproate.

Why Can't You Get Fintepla at a Regular Pharmacy?

The primary reason Fintepla is hard to find at standard pharmacies is a federal requirement called a Risk Evaluation and Mitigation Strategy (REMS). Because fenfluramine (Fintepla's active ingredient) has been associated with valvular heart disease and pulmonary arterial hypertension, the FDA requires a strict safety program before the drug can be dispensed.

Under the FINTEPLA REMS program, three things must happen before a patient can receive the drug:

Prescribers must be certified by enrolling in the FINTEPLA REMS program.

Pharmacies must be REMS-certified — only specialty pharmacies that have enrolled in the program can dispense it.

Patients must enroll and receive a baseline echocardiogram before their first dose.

This means your neighborhood CVS, Walgreens, or independent pharmacy almost certainly cannot fill a Fintepla prescription — not because they ran out, but because they are not enrolled in the REMS program.

What Is the FINTEPLA REMS Program Exactly?

The FINTEPLA REMS (Risk Evaluation and Mitigation Strategy) is a safety program mandated by the FDA. It was put in place because fenfluramine was previously used as a weight-loss drug in the 1990s and was withdrawn from the market after being linked to heart valve damage in adults.

In its current form for epilepsy treatment, the doses of fenfluramine are far lower than those used for weight loss. Clinical trials of up to 3 years in duration found no patients developed valvular heart disease or pulmonary arterial hypertension — but because of the historical association, the FDA still requires ongoing cardiac monitoring. Patients must receive an echocardiogram before starting, every 6 months while on treatment, and once at 3-6 months after stopping Fintepla.

Is Fintepla Actually in a Drug Shortage?

No — as of 2026, Fintepla is not on the FDA's official drug shortage list. The medication itself is manufactured and available. The access barrier is not about supply; it's about distribution restrictions imposed by the REMS program.

However, the REMS requirements create real-world access challenges that can feel like a shortage to families struggling to obtain it:

Insurance prior authorization can take 30-45 days for approval.

Prescribers must be REMS-enrolled, meaning not every neurologist is authorized to prescribe it.

Specialty pharmacies deliver by mail, which introduces timing and coordination issues.

Insurance denials are common and require detailed appeals with seizure logs and prior treatment history.

Which Pharmacies Can Fill Fintepla?

Fintepla is dispensed exclusively through REMS-certified specialty pharmacies. These pharmacies specialize in complex, high-cost medications and typically provide mail delivery. Some major REMS-certified specialty pharmacy networks that may carry Fintepla include:

CVS Specialty (Aetna's preferred specialty pharmacy partner)

Other specialty pharmacies enrolled in the FINTEPLA REMS program

To find a certified specialty pharmacy, contact the FINTEPLA REMS program directly at 1-877-964-3649 or visit FinteplaREMS.com. Your prescriber or epilepsy care team can also guide you to the right pharmacy partner.

What Should You Do If You Can't Get Fintepla?

If your prescription is stuck — whether due to insurance, pharmacy enrollment, or REMS logistics — here are concrete steps to take:

Call ONWARD: UCB's patient support program (1-833-463-7547) can help with insurance navigation, prior authorization support, and copay assistance.

Contact your epilepsy care team: Your neurologist's office can often expedite REMS enrollment and communicate directly with specialty pharmacies.

Use medfinder: [@portabletext/react] Unknown block type "span", specify a component for it in the `components.types` prop contacts pharmacies on your behalf to verify which REMS-certified locations can fill your specific prescription and checks stock — so you can skip the phone tag.

Ask about alternatives: If Fintepla access delays are prolonged, talk to your neurologist about other approved options for Dravet syndrome or LGS, such as Epidiolex (cannabidiol) or Diacomit (stiripentol).

How Long Does It Take to Get Fintepla?

The timeline from prescription to first dose can vary significantly. REMS enrollment typically takes 1-2 weeks. Insurance prior authorization can add another 30-45 days. Expedited reviews for urgent cases are sometimes completed within 72 hours. All told, new patients should expect the process to take at least 2-6 weeks from the time the prescription is written.

If your insurer denies the claim, you can appeal with documentation of seizure frequency, prior medication failures, and genetic testing results for Dravet syndrome. Many families successfully appeal initial denials.

Bottom Line

Fintepla is not in a drug shortage — but the REMS distribution system makes access feel just as difficult. Knowing where to go, who to call, and how to navigate the system is the key to getting this medication for your child or yourself. For a step-by-step guide on finding available stock, see How to find Fintepla in stock near you.